The MUT056399 inhibitor of FabI is a new antistaphylococcal compound. [electronic resource]
Producer: 20120306Description: 4692-7 p. digitalISSN:- 1098-6596
- Acetamides -- pharmacology
- Animals
- Anti-Bacterial Agents -- pharmacology
- Benzamides -- pharmacology
- Drug Resistance, Multiple, Bacterial
- Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) -- antagonists & inhibitors
- Escherichia coli -- drug effects
- Escherichia coli Proteins -- antagonists & inhibitors
- Fatty Acid Synthase, Type II -- antagonists & inhibitors
- Female
- Linezolid
- Methicillin-Resistant Staphylococcus aureus -- drug effects
- Mice
- Microbial Sensitivity Tests
- Mutation
- Oxazolidinones -- pharmacology
- Phenyl Ethers -- pharmacology
- Staphylococcal Infections -- drug therapy
- Staphylococcus aureus -- drug effects
- Vancomycin -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.